Habil Khorakiwala Net Worth

Habil Khorakiwala has an estimated net worth of $1.6 billion, according to Forbes Real-Time Billionaires, Habil Khorakiwala profile (figures as of October 20, 2026). That is up from $1.1 billion in 2008.

Habil Khorakiwala is an Indian business leader in pharmaceuticals and biotechnology. He founded Wockhardt in 1967 and serves as chairman. The company grew from a small drug maker into a multinational group with businesses in generic medicines, formulations, biopharmaceuticals, nutrition products, vaccines, active pharmaceutical ingredients, and hospitals. He also served as Sweden's honorary consul general in Mumbai and, in 2014, became Chancellor of Jamia Hamdard University.

His wealth is tied to Wockhardt, one of India's top makers of generic drugs. He started the business after breaking away from his family's retail empire and building a company focused on healthcare. Wockhardt later expanded into several drug categories and a chain of advanced super speciality hospitals. Leadership also spread across the group, with his son Murtaza running the Mumbai company, his daughter Zahabiya overseeing the hospital arm, and another son leading the charitable foundation.

How Habil Khorakiwala built his fortune

Khorakiwala made his name by building Wockhardt into a major healthcare company. He founded it in 1967 after taking over his father's Worli Chemical Works. The business began as a small firm with 20 employees making over-the-counter drugs. Over time, it expanded into generic medicines, formulations, biopharmaceuticals, nutrition products, vaccines, and active pharmaceutical ingredients. It also developed a hospital business, giving the group another healthcare line beyond drug manufacturing.

His money comes from pharmaceuticals, the field Forbes ties to his fortune. Wockhardt's reach goes beyond India, with manufacturing facilities around the world, and the U.K. counts as one of its top markets. The company is described by Forbes as one of India's top makers of generic drugs. Family members handle different parts of the group, which helps explain how the business spans medicines, hospitals, and the charitable foundation under one broader enterprise.

What Forbes says about his net worth

Forbes has tracked Khorakiwala's fortune for years, and the numbers have moved up and down. It put his net worth at $1.1 billion in 2008, then $1.6 billion in 2013, and $2.1 billion in 2015. After that, the estimate fell to $1 billion in 2016. Forbes later valued him at $1.3 billion in 2017, 2018, 2025, and 2026 on its World's Billionaires List.

The latest Forbes update is higher than those annual list figures. Forbes' real-time billionaires tracker showed him at $1.6 billion as of October 20, 2026. The core reason for his wealth remains the same: his long-running stake in a pharmaceutical and healthcare company he founded and still chairs. Because that fortune is tied to one main business, Forbes estimates can change over time while the source of wealth stays centered on Wockhardt.